SARA HIGBEE: Open Payments
NPI 1659035582 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,457 in 134 payments from 16 companies in 2025. Trend: 2023 $1,015 · 2024 $1,090 · 2025 $6,457
Food & beverage: $3,566Speaker / faculty: $2,772Education: $117Travel & lodging: $2
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $3,561 |
| AstraZeneca Pharmaceuticals LP | 28 | $599 |
| GlaxoSmithKline, LLC. | 22 | $416 |
| Verona Pharma, Inc. | 26 | $398 |
| Insmed, Inc. | 15 | $266 |
| United Therapeutics Corporation | 5 | $255 |
| Regeneron Healthcare Solutions, Inc. | 5 | $217 |
| Pulmonx Corporation | 3 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $143 |
| Actelion Pharmaceuticals US, Inc. | 3 | $106 |
Products named: DUPIXENT, Ohtuvayre, FASENRA, NUCALA, Arikayce, CHARTIS CATHETER, OPSUMIT, TEZSPIRE.
Industry payments across MI — which companies pay providers there.
